Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
- Written by PR Newswire
 |
- This Phase 2 trial is evaluating three vaccine candidates: COVID-Influenza Combination, stand-alone influenza and high-dose COVID
- Preliminary topline immune responses for all three vaccine candidates were robust versus authorized comparators
- For the stand-alone influenza vaccine candidate, HAI responses were 31 to 56% higher for all four influenza...
